MCY
Mercury NZ Limited
🇦🇺 ASX
👑 Overview
📈 Performance
💰 Dividends
💵 Cost
🤓 Advanced
👨👩👧👦 Community
📈
N/A
Annual Growth
5 years average annual growth
💰
3.11%
Annual dividend yield
Based on the most recent dividend
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
16
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
Mercury NZ Ltd. engages in the generation and distribution of electricity from hydro, geothermal, and gas. The firm generates electricity from renewable resources, such as hydro, geothermal and wind. Its products and services consist of generation/wholesale and retail. Generation/wholesale market segment encompasses activity associated with electricity generation, electricity trading, generation development activities. The company is engaged in sale of electricity to both commercial and industrial customers and the retail segment. Retail segment encompasses activity associated with sale of energy, and related services, to customers in New Zealand. The retail operations serve commercial and residential (small medium sized businesses) customers. The company offers pre-pay electricity product, GLOBUG. The company manages several subsidiary enterprises, such as its EV Subscription Service. The firm is also engaged in the business of gas, telecommunications business, and retail electricity supply business.
📈 Performance
Price History
+171.04%
1M
10Y
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💰 Dividends
Payouts
💰 Annual Dividend Yield*
3.11%
💰 Annual Dividend Earnings Per $1,000 invested**
$31.15
💰 Most Recent Dividend Franked Percentage Estimate
0.00%
💰 Average Dividend Franked Percentage Estimate
0.00 %
💰 Dividend reinvestment
* Based on the most recent dividend
** Calculated by multiplying the most recent dividend yield by $1,000
Dividend History
1Y
5Y
10Y
Graph
Table
Year
Yearly Dividend Earnings Per Share
Franking Estimate
2024
$0.00
0.00%
2023
$0.00
0.00%
2022
$0.18
0.00%
2021
$0.16
0.00%
2020
$0.15
0.00%
2019
$0.15
0.00%
2018
$0.14
0.00%
2017
$0.13
0.00%
2016
$0.13
0.00%
2015
$0.13
0.00%
💵 Costs
💼
0%
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$5.99
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in MCY
16
📊 Total Capital Earnings
N/A
🔃 Average investment frequency
N/A
💵 Average investment amount
N/A
⏰ Last time a customer invested in MCY
493 days
MCY investor breakdown
💵 Income of investors
More than 200k
150k - 200k
100k - 150k
25%
50k - 100k
50%
Less than 50k
25%
👶 Age of investors
18 - 25
26 - 34
69%
35 - 90
25%
🙋 Legal gender of investors
Female
63%
Male
38%
Pearlers who invest in MCY also invest in...
VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.
📊 Share price
$90.18 AUD
NULL AUSTRALIA
NULL BETA
ACDC.AX was created on 2018-08-30 by Global X. The fund's investment portfolio concentrates primarily on theme equity. The Fund aims to provide investors with a return that (before fees and expenses) tracks the performance of the Solactive Battery ValueChain Index (the Index).
📊 Share price
$100.01 AUD
NULL GLOBAL
NULL OTHER
NULL SMART BETA
NULL THEMATIC
NULL INDEX
VGS.AX was created on 2014-11-18 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard MSCI International Shares Index ETF seeks to track the return of the MSCI World ex-Australia Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax.
📊 Share price
$104.08 AUD
NULL GLOBAL
NULL EX AUSTRALIA
NULL BETA
VDHG.AX was created on 2017-11-20 by Vanguard. The fund's investment portfolio concentrates primarily on target outcome asset allocation. Vanguard Diversified High Growth Index ETF seeks to track the weighted average return of the various indices of the underlying funds in which it invests, in proportion to the Strategic Asset Allocation, before taking into account fees, expenses and tax.
📊 Share price
$57.36 AUD
NULL GLOBAL
NULL SMART BETA
ETHI.AX was created on 2017-01-05 by BetaShares. The fund's investment portfolio concentrates primarily on total market equity. The fund aims to track the performance of an index (before fees and expenses) that includes a portfolio of large global stocks identified as Climate Leaders that have also passed screens to exclude companies with direct or significant exposure to fossil fuels or engaged in activities deemed inconsistent with responsible investment considerations.
📊 Share price
$12.45 AUD
NULL GLOBAL
NULL SMART BETA
NULL ETHICAL
NULL EX AUSTRALIA
Want more shares? Try these...
Medlab Clinical Ltd. engages in the development of therapeutic pathways for diagnosed chronic diseases. The company is headquartered in Alexandria, New South Wales. The company went IPO on 2015-07-14. The firm is investigating a range of prescription and non-prescription solutions for unmet patient needs across a variety of therapeutic areas, including pain management, mental health, gut health, diabetes, and allergies. The Company’s drug candidates include NanaBis, NanoCBD and NanoCelle. Medlab’s pipeline comprises a range of small and large molecules from repurposing generic medicines to enhancing the delivery of immunotherapies. The firm's lead drug candidate, NanaBis, is under development for cancer bone pain as an alternative to opioid use and NanoCBD for mental stress . The firm also has a drug delivery platform called NanoCelle, which is wholly owned by Medlab and developed in Medlab’s owned Office of the Gene Technology Regulator (OGTR) registered laboratory.
📊 Share price
$6.60 AUD
Middle Island Resources Ltd. engages in the acquisition, exploration and development of gold deposits. The company is headquartered in Perth, Western Australia. The company went IPO on 2010-12-16. The firm operates through two segments: Australia and West Africa. The Company’s Barkly Copper-Gold Super Project comprises of 14 exploration licenses granted and two pending applications, which covers approximately 5,510 square kilometers (km2) within the Barkly region of the Northern Territory (NT).
📊 Share price
$0.04 AUD
Mariner Corp. Ltd. engages in investment activities and corporate actions. The company is headquartered in North Sydney, New South Wales. The firm is engaged in investment activities and corporate actions. The firm operates across two geographical segments being Australia and Hong Kong. Its investment portfolio comprises quoted equity investments and fixed and variable interest loans, and investments in other schemes. The firm makes strategic investments in listed companies and unlisted companies. The company is also focused on identifying and implementing business opportunities in the market. The Company’s subsidiaries include Mariner Asset Management Limited, Mariner Investments Limited, and Mariner International Limited.
📊 Share price